Literature DB >> 479764

Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.

M J Polley, R L Nachman.   

Abstract

Thrombin-mediated platelet aggregation and release is enhanced by the presence of C3, C5, C6, C7, C8, and C9 of human complement. The interaction of thrombin with its receptor on the platelet membrane initiates activation of complement on the platelet surface. Trypsin-mediated platelet function is not enhanced by the addition of complement, probably because trypsin has no receptor on the platelet surface so activation of complement is triggered in the fluid phase and not on the platelet surface. Activation of complement by thrombin led to production of dimers of the C5b-9 complex on the platelet surface. These complexes were eluted from the platelet membrane and were identified physicochemically and morphologically. The mechanism of complement-induced enhancement of platelet function is not clear, however, it probably is mediated via the arachidonic acid transormation pathway because this activity was blocked by known inhibitors of cyclo-oxygenase, namely, aspirin and indomethacin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 479764      PMCID: PMC2185636          DOI: 10.1084/jem.150.3.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Complement abnormalities in human disease.

Authors:  H J Müller-Eberhard
Journal:  Hosp Pract       Date:  1978-12

2.  The perturbation of thrombin binding to human platelets by trypsin and neuraminidase.

Authors:  P Ganguly
Journal:  Biochim Biophys Acta       Date:  1977-06-23

3.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

4.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

Authors:  U R Nilsson; R H Tomar; F B Taylor
Journal:  Immunochemistry       Date:  1972-07

5.  The ninth component of human complement: isolation, description and mode of action.

Authors:  U Hadding; H J Müller-Eberhard
Journal:  Immunology       Date:  1969-06       Impact factor: 7.397

6.  Molecular nature of the complement lesion.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

7.  C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.

Authors:  G Biesecker; E R Podack; C A Halverson; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

8.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

9.  The human complement system in thrombin-mediated platelet function.

Authors:  M J Polley; R Nachman
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  25 in total

1.  Activation of plasma systems and blood cells by endotoxin in rabbits.

Authors:  N J Jansen; W van Oeveren; B H Hoiting; C R Wildevuur
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Complement and clot.

Authors:  Vahid Afshar-Kharghan
Journal:  Blood       Date:  2017-04-20       Impact factor: 22.113

Review 3.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

Review 5.  The role of blood cells and of the vessel wall in the induction of intravascular coagulation.

Authors:  E F Lüscher
Journal:  Klin Wochenschr       Date:  1982-07-15

6.  Complement 3 is involved with ventilator-induced lung injury.

Authors:  Kazue Takahashi; Dalia Saha; Ivany Shattino; Vasile I Pavlov; Gregory L Stahl; Paul Finnegan; Marcos F Vidal Melo
Journal:  Int Immunopharmacol       Date:  2011-10-05       Impact factor: 4.932

7.  Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).

Authors:  Gurpanna Saggu; Claudio Cortes; Heather N Emch; Galia Ramirez; Randall G Worth; Viviana P Ferreira
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

8.  Interaction of rat platelets with Listeria monocytogenes.

Authors:  C J Czuprynski; E Balish
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.

Authors:  R J Falk; A P Dalmasso; Y Kim; C H Tsai; J I Scheinman; H Gewurz; A F Michael
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

Review 10.  Platelet mediated complement activation.

Authors:  Ellinor I B Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.